Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.
about
Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocolPemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients.Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.Antimetabolites and cancer: emerging data with a focus on antifolates.Pemetrexed in advanced non-small-cell lung cancer.Lipoplatin formulation review article.Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.Pemetrexed in thoracic cancer.Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.Role of pemetrexed in non-small cell lung cancer.Pemetrexed for the treatment of non-small-cell lung cancer.Emerging role of pemetrexed in ovarian cancer.Pemetrexed and its emerging role in the treatment of thoracic malignancies.Pemetrexed (Alimta): a novel multitargeted antifolate agent.Pemetrexed: a novel antifolate agent enters clinical practice.Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma.A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumoursTwo consecutive days of treatment with liposomal cisplatin in non-small cell lung cancerClinical activity of pemetrexed: a multitargeted antifolate anticancer agent.Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed.Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesotheliomaPhase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype.Vinflunine: review of a new vinca alkaloid and its potential role in oncology.Pemetrexed in heavily pretreated non-small-cell lung cancer patients: case report and review of the literature.The place of pemetrexed in the management of non-small-cell lung cancer patients.Pemetrexed for the treatment of non-small cell lung cancer.Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer.Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.
P2860
Q28209997-3A363074-9FCC-49BD-9BE2-4966F0A4C1ACQ33389316-81EFEF93-0D25-43D6-83D7-BE03B1A33F2DQ33402765-97D9D3CA-6128-41AF-B6FA-B5E223BC3928Q33530405-2AEB18F5-7C62-477B-8AE3-5C4576F95168Q34113895-47B092DF-53F8-44EE-9644-8F65D620CB05Q34214923-394F214C-C9B6-4FE7-B3DB-097BA556BAAEQ34277874-6296A7CD-186E-4E5F-84DE-CF3809881F65Q34516941-F91E27B1-C7EE-4DBB-A5B8-CF46D5324AD5Q34517532-846A67E8-1FE4-4FE2-A550-E7189D78B86FQ34609132-48E7C283-6ABD-42E7-8256-28B4DF59B6FFQ35003631-760F095D-2911-4E51-9FD5-9DF21B4F6E4EQ35015611-B43160E0-5713-4DFA-AC12-B4F934B95F58Q35117095-6A0D1AD4-DBB5-4CD4-A0F2-1F9523A1484BQ35117722-01D30C00-B1ED-4343-845C-DDA4AAC64DAAQ35843663-2AB39920-DE7E-46C2-B81B-25EB3884E8D3Q35845236-44A09405-4928-433F-8827-CF77E2F3EE35Q36166846-00928420-EB10-41A1-84C3-4DABDCFC883FQ36403215-AD07014C-A194-4662-9552-7DB5989039DCQ36429607-0E09C75C-837A-4470-BEFD-8E82596344FEQ36441443-48F2E84F-444C-49DD-9605-56BA8502281BQ36614907-75334065-EDA9-43F0-8312-0A9B118E38D7Q36822893-4FFBEE3B-4FF2-43ED-918D-94D06327F532Q37212223-D8D6B9F2-E41B-4007-BD7D-94E416D471C9Q37388593-84ACF6CD-D0AA-42FC-812C-6957E11BF16AQ37449024-577BB393-38CA-441F-9663-7E2390F00BC3Q37768280-E0937ECB-4D3A-4C0F-9769-0C195FE13E1CQ37818301-3A3AB21B-F3FA-41A8-9B69-4C6EBB5F6865Q38087999-07A19D9C-017F-4CE1-9001-34BF56B7D8B0Q38107552-C96642BA-095A-488D-8A6B-C36A955C425DQ38190461-F555D541-CCC4-494E-97DC-5861E7C1E75CQ38771030-70618D74-77CC-4C11-A58E-8655FFA826ADQ38983310-20EF054D-2700-47F3-B9C1-81082872EAD3Q45928394-17878F0D-065D-4643-9F3A-33C2D240C023
P2860
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Phase II study of pemetrexed d ...... Canada Clinical Trials Group.
@en
Phase II study of pemetrexed d ...... Canada Clinical Trials Group.
@nl
type
label
Phase II study of pemetrexed d ...... Canada Clinical Trials Group.
@en
Phase II study of pemetrexed d ...... Canada Clinical Trials Group.
@nl
prefLabel
Phase II study of pemetrexed d ...... Canada Clinical Trials Group.
@en
Phase II study of pemetrexed d ...... Canada Clinical Trials Group.
@nl
P2093
P2860
P1433
P1476
Phase II study of pemetrexed d ...... Canada Clinical Trials Group.
@en
P2093
Eisenhauer E
Johnson RD
Rusthoven J
Shepherd FA
P2860
P304
P356
10.1002/1097-0142(20010801)92:3<595::AID-CNCR1359>3.0.CO;2-D
P407
P577
2001-08-01T00:00:00Z